Stanford Cancer Center ( Site 0036) — Palo Alto, California

Stanford Cancer Center ( Site 0036) is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford Cancer Center ( Site 0036) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Prostate Cancer Metastatic, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Center ( Site 0036)?

Stanford Cancer Center ( Site 0036) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Center ( Site 0036) conducted?

Stanford Cancer Center ( Site 0036) has 2 clinical trials on record, with 2 currently active. Their work covers Prostate Cancer Metastatic, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Is Stanford Cancer Center ( Site 0036) accredited by Crixeo Health?

Stanford Cancer Center ( Site 0036) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Center ( Site 0036)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.